Distribution of perospirone to melanin in pigmented rats
- 47 Downloads
Following the administration of [Carbonyl-14C]perospirone ([CO-14C]perospirone) and [isothiazolyl-3-14C]perospirone ([TH-14C]perospirone) to male-pigmented rats at a single oral dose of 10 mg/kg, serum radioactivity reached maxima of 499 ng eq./g and 446 ng eq./g, respectively, at 1 hour, then decreased rapidly to below 2 ng eq./g at 168 hours, and radioactivity in eyeballs reached maxima of 576 ng eq./g and 3449 ng eq./g, respectively, at 24 hours, then decreasing slowly to become 120 ng eq./g and 314 ng eq./g at 26 weeks. Apparent elimination half-lives of radioactivity in eyeballs were 197 and 126 days for [CO-14C]perospirone and [TH-14C]perospirone, respectively. With radioluminograms, radioactivity was detected specifically in the uvea, reaching maxima at 168 hours for [CO-14C]perospirone and at 24 hours for [TH-14C]perospirone.
In addition to unchanged compound, many metabolites were found in serum and eyeballs, but those were also detectable in SD albino rats and cynomolgus monkeys. Among radioactive components in eyeballs after administration of [CO-14C]perospirone, ratios of ID-15036 and MX11 followed by unchanged compound and MX9 are high. After administration of [TH-14C]perospirone ID-11614 accounted for nearly half of the radioactivity. Values decreased in line with radioactivity in eyeballs over time and 26 weeks only a few polar metabolites could be detected.
KeywordsPerospirone melanin distribution rat
Unable to display preview. Download preview PDF.
- 1.Hirose A., Kato T., Ohno Y., Shimizu H., Tanaka H., Nakamura M., Katsube J. (1990): Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions. Japan. J. Pharmacol., 53, 321–329.Google Scholar
- 2.Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Disposition of SM-9018 after Single Oral Administration to Rats and Protein Binding to Serum of Human and Animals. Clinical Report, 31(2), 543–568.Google Scholar
- 3.Mizuno Y., Kanamaru H., Nakatsuka I., Miyoshi K., Hanawa S., Hayashi K., Esumi Y. (1997): Disposition of [carbonyl-14C]SM-9018 in Cynomolgus monkeys. Clinical Report, 31(2), 799–809.Google Scholar
- 4.Mizuno Y., Kanamaru H., Nakatsuka I., Kitajima S., Mitsuoka C., Kodama R. (1997): Disposition of [isothiazolyl-14C] SM-9018 in Cynomolgus monkeys. Clinical Report, 31(2), 811–819.Google Scholar
- 5.Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Metabolic Profile in Serum after Single Oral Administration of14C-SM-9018 to Rats. Clinical Report, 31(2), 689–705.Google Scholar
- 6.Fujimoto K., Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Identification of Metabolites of SM-9018. Clinical Report, 31(2), 581–657.Google Scholar
- 13.Lullman-Rauch R. (1991): Lipidosis of the retina due to catinic amtiphilic drugs, rat. In: T. C. Jones, U. Mohr, and R. D. Hunt, (Eds). Eye and Ear, Monographs on Pathology of Laboratory Animals. Berlin: Springer-Verlag, 87–92.Google Scholar
- 16.Yamada T., Yamaguchi T., Miyata K., Inoue T., Nakayama Y., Yoshioka K., Kamita Y., Seki T., Okuno Y., Hosokawa T. (1997): Twelve-month Repeated Oral Toxicity Study of SM-9018 in Rats. Clinical Report, 31(2), 309–358.Google Scholar
- 17.Koizumi H., Konishi H., Suzuki S., Hirata M. (1990): Thirteen-weeks Repeated Oral Toxicity Study with Four-weeks Recovery Period of perospirone in Monkeys. Preclinical Research Laboratories, Inc. inhouse report.Google Scholar
- 18.Koizumi H., Konishi H., Suzuki S., Hirata M. (1993): Fifty-two-weeks Repeated Oral Toxicity Study of perospirone in Monkeys. Preclinical Research Laboratories, Inc. in-house report.Google Scholar